CVS Health Corporation announced a 7% increase in Q1 2025 revenue to $94.6B, with net income rising to $1.78B from $1.12B in 2024. The company revised its 2025 cash flow guidance t...
Biogen Inc. reports a 6% increase in Q1 revenue for 2025, totaling $2.4 billion, despite a dip in earnings per share. CEO Christopher Viehbacher emphasizes the company's strategic ...
Biogen Inc. reports a 6% revenue increase to $2.4 billion in Q1 2025, despite a dip in earnings per share. CEO Christopher Viehbacher emphasizes the strategic shift towards diversi...
Biogen Inc. reports a 6% increase in Q1 2025 revenue to $2.4 billion, despite a dip in earnings per share. CEO Christopher Viehbacher emphasizes the company's strategic growth and ...
Biogen Inc. reports a 6% revenue growth to $2.4 billion in Q1 2025, with a notable shift in revenue sources outside its MS business, despite a decrease in GAAP earnings per share.
Linde plc reports steady Q1 2025 sales at $8.1 billion, with a 5% rise in diluted earnings per share. Mixed regional performance noted, with growth in the Americas but declines in ...
CVS Health Corporation announced a 7% increase in Q1 2025 revenue to $94.6 billion, with net income rising to $1.78 billion. The company adjusted its full-year cash flow guidance b...
Biogen Inc. reported a 6% increase in Q1 2025 revenue to $2.4 billion, despite a drop in earnings per share. CEO Christopher Viehbacher emphasized the strategic shift towards diver...
Airbus SE reports a 6% revenue increase to €13.5 billion in Q1 2025, with net income up by 33%. CEO Guillaume Faury highlights progress amidst supply chain challenges.
Coca-Cola's Q1 2025 results show a 2% revenue decline to $11.1B, with a 6% rise in organic revenues. EPS grew by 5%, and operating income soared by 71%, reflecting the company's ab...
Pfizer Inc. announced an 8% revenue decline to $13.7 billion in Q1 2025, with a 5% drop in net income and EPS. CFO David Denton highlights operational efficiency driving financial ...
Coca-Cola's Q1 2025 results show a 2% revenue decline to $11.1 billion, with a 6% rise in organic revenues. EPS grew by 5% to $0.77, and operating income soared by 71% to $3.66 bil...
Pfizer Inc. announced an 8% decrease in Q1 revenue to $13.7 billion for FY2025, with a 5% drop in net income and EPS. CFO David Denton highlights operational efficiency driving res...
General Motors announced a 2.3% revenue increase in Q1 2025 to $44.02B, beating expectations despite a 6.6% drop in net income. Adjusted EPS rose 6.1%, but the company suspended it...
The Coca-Cola Company announced a 2% decline in Q1 2025 net revenues to $11.1 billion, alongside a 6% rise in organic revenues. EPS grew by 5% to $0.77, and operating income soared...
AstraZeneca announces a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6% and core operating profit growing by 12%. The company forecasts continued growt...
AstraZeneca PLC announced a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6%. The company forecasts continued growth, aiming for $80 billion in total re...
Adidas AG reports a strong first quarter in 2025 with net sales of €6.15 billion, a 12.7% increase year over year. The company also saw significant growth in net income and earning...
Colgate-Palmolive announces a 3.1% decrease in Q1 2025 net sales to $4.9B, yet surpasses expectations with a 2% EPS increase and 1.02% net income growth. The company forecasts orga...
SLB announced a 3% year-on-year revenue decline to $8.49 billion in Q1 2025, with net income dropping by 25%. CEO cited varied global market performances affecting results.
Colgate-Palmolive's Q1 2025 financial report shows a 3.1% drop in net sales to $4.9B, yet outperforms analysts' predictions with a 2% EPS increase to $0.85 and a 1.02% rise in net ...
Colgate-Palmolive's Q1 2025 financials show a 3.1% net sales drop to $4.9B, yet EPS and net income rise, beating expectations. The company forecasts organic sales growth of 2%-4% f...
Merck & Co. reported a 2% year-on-year sales decline to $15.5 billion in Q1 2025, but net income rose by 7% to $5.1 billion. CEO Robert M. Davis emphasized the company's focus on i...
Merck & Co., Inc. reports a 2% decrease in Q1 sales to $15.5 billion but achieves a 7% growth in net income and EPS. CEO highlights progress in medicines and vaccines, with stock p...
Sanofi SA announced a 10.8% increase in Q1 net sales to €9.9 billion, with notable growth in net income and EPS. CEO Paul Hudson reaffirmed the company's 2025 outlook, highlighting...
Sanofi SA reports a 10.8% annual increase in Q1 2025 net sales to €9.9 billion, with significant growth in net income and EPS, reaffirming its positive outlook for 2025.
Sanofi SA reports a 10.8% increase in Q1 2025 net sales to €9.9 billion, with significant growth in net income and EPS, affirming its 2025 financial guidance.
GE Vernova Inc. reports an 11% revenue increase to $8B in Q1 2025, surpassing estimates and turning last year's loss into a $264M net income. Orders grew by 8%, and the company rea...
GE Vernova Inc. reports an 11% revenue increase to $8B in Q1 2025, surpassing estimates and turning last year's net loss into a $264M net income. Orders grew by 8%, and the company...
GE Vernova Inc. reports an 11% revenue increase to $8B in Q1 2025, with net income turning around to $264M from a loss. Orders grew by 8%, and the company reaffirms its 2025 revenu...
AT&T Inc. reports a 2% revenue increase to $30.6 billion in Q1 2025, with net income rising to $4.7 billion. CEO John Stankey highlights customer trust in AT&T Fiber and 5G service...
Verizon Communications reports a 1.5% revenue increase to $33.5 billion in Q1 2025, with net income up by 6.3%. The company forecasts continued growth in wireless service revenue a...
